Clinical trial
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
NCT06474533 is registered in ClinicalTrials.gov with Thomas Hope as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- Lead sponsor
- Thomas Hope
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 21, 2024
- Completion date
- August 31, 2028
- Enrollment
- 199 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial neoplasm